Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Histology and Histopathology

• Publication date

  2012-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14670/HH-27.1315PMID 22936450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients

  2011cited by this paper
• Molecular pathology of breast cancer: the journey from traditional practice toward embracing the complexity of a molecular classification.

  2011cited by this paper
• Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

  2010cited by this paper
• COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer

  2010cited by this paper
• Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow

  2009cited by this paper
• COX-2 expression in canine normal and neoplastic mammary gland.

  2009cited by this paper
• Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

  2009cited by this paper
• COX-2 Expression Does Not Correlate with Microvessel Density in Breast Cancer

  2009cited by this paper
• Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.

  2008cited by this paper
• Vascularization in Primary Breast Carcinomas: Its Prognostic Significance and Relationship with Tumor Cell Dissemination

  2008cited by this paper
• COX‐2 expression in lobular in situ neoplasia of the breast: correlation with histopathological grading system according to the Tavassoli classification

  2007cited by this paper
• Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

  2007cited by this paper
• COX-2 Expression in Invasive Breast Cancer: Correlation With Prognostic Parameters and Outcome

  2007cited by this paper
• Quantitative Analysis of Breast Cancer Tissue Microarrays Shows High Cox-2 Expression Is Associated with Poor Outcome

  2007cited by this paper
• Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium

  2006cited by this paper
• Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.

  2006cited by this paper
• Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast Carcinoma

  2005cited by this paper
• COX‐2 expression in DCIS: correlation with VEGF, HER‐2/neu, prognostic molecular markers and clinicopathological features

  2005cited by this paper
• Mechanisms of Disease: inflammatory mediators and cancer prevention

  2005cited by this paper
• A pooled analysis of bone marrow micrometastasis in breast cancer.

  2005cited by this paper
• Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression.

  2004cited by this paper
• Cyclooxygenase 2 is a key enzyme for inflammatory cytokine‐induced angiogenesis

  2004cited by this paper
• Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER‐negative, but not ER‐positive, breast cancer

  2004cited by this paper
• Elevated expression of cyclooxygenase‐2 in breast cancer and ductal carcinoma in situ has no correlation with established prognostic markers

  2004cited by this paper
• COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

  2004cited by this paper
• Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer.

  2003cited by this paper
• Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival

  2003cited by this paper
• Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysis

  2003cited by this paper
• Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice.

  2003cited by this paper
• Cyclo-oxygenase-2 (COX-2) mRNA expression correlates with progesterone receptor positivity in human breast cancer.

  2003cited by this paper
• Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

  2003cited by this paper
• Correlation between cyclooxygenase-2 expression and angiogenesis in human breast cancer.

  2003cited by this paper
• Lack of prognostic effect of Cox-2 expression in primary breast cancer on short-term follow-up.

  2003cited by this paper
• Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

  2003cited by this paper
• Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis.

  2003cited by this paper
• Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer.

  2002cited by this paper
• Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

  2002cited by this paper
• Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications

  2002cited by this paper
• Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.

  2002cited by this paper
• Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis

  2001cited by this paper
• Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics.

  2001cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.

  1998cited by this paper
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up

  1991cited by this paper
• Prostaglandins and breast cancer.

  1977cited by this paper

• Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2

  2021cites this paper
• The persisting puzzle of racial disparity in triple negative breast cancer: looking through a new lens.

  2019cites this paper
• An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment

  2019cites this paper
• Suppression of cyclooxygenase 2 increases chemosensitivity to sesamin through the Akt‑PI3K signaling pathway in lung cancer cells.

  2018cites this paper
• Abstract. Safe, affordable and efficacious agents are urgently required for cancer prevention. Sesamin, a lipid‐soluble lignan from sesame (Sesamum indicum) displays anticancer activities through an unknown mechanism. In the present study, the anticancer activity of sesamin via cyclooxygenase 2 (COX

  2018cites this paper
• DNA methylation at enhancers identifies distinct breast cancer lineages

  2017cites this paper
• Expression of cyclooxygenase-1 and cyclooxygenase-2, syndecan-1 and connective tissue growth factor in benign and malignant breast tissue from premenopausal women

  2017cites this paper
• The prognostic impact of COX‐2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size

  2017cites this paper
• Characterisation of triple negative breast carcinoma and identification of the value of immunohistochemical markers and stromal tumour infiltrating lymphocytes

  2017cites this paper
• Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells

  2017cites this paper
• Cyclooxygenase-2 (COX2) and p53 protein expression are interdependent in breast cancer but not associated with clinico-pathological surrogate subtypes, tumor aggressiveness and patient survival.

  2016cites this paper
• Integration of Tumor and Host Factors – Implications for Breast Cancer Prognosis

  2016cites this paper
• Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis

  2016cites this paper
• Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013

  2015cites this paper
• Increased Eicosanoid Levels in the Sugen/Chronic Hypoxia Model of Severe Pulmonary Hypertension

  2015cites this paper
• Cyclooxygenase-2 expression in invasive breast carcinomas of no special type and correlation with pathological profiles suggest a role in tumorigenesis rather than cancer progression.

  2015cites this paper
• Expression of integrin α3β1 and cyclooxygenase-2 (COX2) are positively correlated in human breast cancer

  2014cites this paper
• Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients

  2014cites this paper
• Effect of cycloxygenase-2 silencing on the malignant biological behavior of MCF-7 breast cancer cells

  2014cites this paper
• Effects and mechanism of downregulation of COX‑2 expression by RNA interference on proliferation and apoptosis of human breast cancer MCF‑7 cells.

  2014cites this paper
• Stromal, rather than epithelial cyclooxygenase-2 (COX-2) expression is associated with overall survival of breast cancer patients

  2014influential citation
• Novel prognostic markers for patients with triple-negative breast cancer.

  2013cites this paper
• Протеомные исследования, направленные на поиск маркеров рака молочной железы (обзор литературы)

  2013cites this paper
• The Obesity-Inflammation-Eicosanoid Axis in Breast Cancer

  2013cites this paper
• Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma

  2012cites this paper